Literature DB >> 19854621

High remission rates from an initial ultra-high risk state for psychosis.

Andor E Simon1, Daniel Umbricht.   

Abstract

OBJECTIVE: To investigate the proportion of patients among subjects initially identified as fulfilling the ultra-high risk (UHR) criteria for psychosis using the Scale of Prodromal Symptoms (SOPS) who fully remitted after one year.
METHOD: Seventy-two patients between 14 and 40 years who were referred to the Bruderholz Early Psychosis Outpatient Service in Switzerland and who met UHR criteria were included in the present study. At 1-year follow-up, data for 52 patients were available. Patients with transition to psychosis and patients with sustained UHR criteria were defined as 'cases', and patients with remission from UHR criteria as 'non-cases'. We compared clinical and socio-demographic characteristics between these two patient groups at baseline.
RESULTS: 13.5% of the patients converted to full-blown psychosis within one year, one quarter displayed sustained UHR criteria, and 59.2% of the patients fully remitted from the initial UHR status. Outcome was independent of medication or treatment status. 'Cases' and 'non-cases' did not differ significantly on socio-demographic and clinical variables at baseline.
CONCLUSIONS: The chance of remission to a non-risk state was over fourfold higher than the chance of conversion to psychosis within a year of establishing UHR status. Our data underline that the commonly used symptoms to identify UHR patients are often transitory and may not capture the stable core of developing psychosis. This highlights the danger of provoking anxiety and stigmatization in mislabeled individuals and missing true at-risk patients who present features of the psychosis core, but who do not yet-or maybe never will-manifest positive symptoms. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19854621     DOI: 10.1016/j.schres.2009.10.001

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  23 in total

Review 1.  Prediction of conversion to psychosis: review and future directions.

Authors:  Dylan G Gee; Tyrone D Cannon
Journal:  Braz J Psychiatry       Date:  2011-10       Impact factor: 2.697

2.  At clinical high risk for psychosis: outcome for nonconverters.

Authors:  Jean Addington; Barbara A Cornblatt; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen
Journal:  Am J Psychiatry       Date:  2011-04-15       Impact factor: 18.112

3.  Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.

Authors:  T H Zhang; H J Li; K A Woodberry; L H Xu; Y Y Tang; Q Guo; H R Cui; X H Liu; A Chow; C B Li; K D Jiang; Z P Xiao; L J Seidman; J J Wang
Journal:  Epidemiol Psychiatr Sci       Date:  2016-04-08       Impact factor: 6.892

4.  Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.

Authors:  Danielle A Schlosser; Sarah Jacobson; Qiaolin Chen; Catherine A Sugar; Tara A Niendam; Gang Li; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2011-08-08       Impact factor: 9.306

Review 5.  Antipsychotic interventions in prodromal psychosis: safety issues.

Authors:  Chen-Chung Liu; Arsime Demjaha
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

6.  Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.

Authors:  G Brucato; M D Masucci; L Y Arndt; S Ben-David; T Colibazzi; C M Corcoran; A H Crumbley; F M Crump; K E Gill; D Kimhy; A Lister; S A Schobel; L H Yang; J A Lieberman; R R Girgis
Journal:  Psychol Med       Date:  2017-03-02       Impact factor: 7.723

7.  Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk state.

Authors:  André Schmidt; Renata Smieskova; Andor Simon; Paul Allen; Paolo Fusar-Poli; Philip K McGuire; Kerstin Bendfeldt; Jacqueline Aston; Undine E Lang; Marc Walter; Ernst-Wilhelm Radue; Anita Riecher-Rössler; Stefan J Borgwardt
Journal:  J Psychiatry Neurosci       Date:  2014-07       Impact factor: 6.186

8.  Early and broadly defined psychosis risk mental states.

Authors:  Matcheri S Keshavan; Lynn E DeLisi; Larry J Seidman
Journal:  Schizophr Res       Date:  2010-11-30       Impact factor: 4.939

Review 9.  Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review.

Authors:  Megan S Farris; Mohammed K Shakeel; Jean Addington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-03       Impact factor: 4.328

10.  Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging study.

Authors:  Renata Smieskova; Paul Allen; Andor Simon; Jacqueline Aston; Kerstin Bendfeldt; Jürgen Drewe; Kerstin Gruber; Ute Gschwandtner; Markus Klarhoefer; Claudia Lenz; Klaus Scheffler; Rolf-Dieter Stieglitz; Ernst-Wilhelm Radue; Philip McGuire; Anita Riecher-Rössler; Stefan J Borgwardt
Journal:  Hum Brain Mapp       Date:  2011-09-16       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.